5, 8-dihydro-1, 7-naphthyridine derivatives as GLP-1 agonists for treatment of diabetes

CN119212993APending Publication Date: 2024-12-27GASHERBRUM BIO INC
View PDF 38 Cites 0 Cited by

Patent Information

Application Number
CN202380040463.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2023-03-09
Filing Date
2023-03-20
Publication Date
2024-12-27

Smart Images

  • Figure BDA0005134182470000011
    Figure BDA0005134182470000011
  • Figure BDA0005134182470000013
    Figure BDA0005134182470000013
  • Figure BDA0005134182470000101
    Figure BDA0005134182470000101
Patent Text Reader

Abstract

The present disclosure relates generally to GLP-1 agonists and pharmaceutical compositions comprising the GLP-1 agonists, and methods for treating GLP-1 related diseases, disorders, or conditions.
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Reduced moisture chemical reactions

    IN256918B

  • Anti-nausea drug combinations

    US10071088B2

  • Combinations of amisulpride and another anti-emetic for treating nausea and vomiting

    US10322106B2

  • Use of amisulpride as an anti-emetic

    US10525033B2

  • Compositions and methods for treating centrally mediated nausea and vomiting

    US10828297B2